---
title: "European stocks \"Eleven Arhats\" | Astrazeneca fell about 2.2%, Sanofi, GSK, and Novo Nordisk dropped by up to 1.7%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/227094107.md"
description: "On Tuesday (February 4), AstraZeneca fell about 2.2%, while Sanofi, GSK, and Novo Nordisk dropped by up to 1.7%. Astra Merck Holdings rose by 0.35%, and Novo Nordisk fell by 1.18%. Other companies such as L'Oréal, Novartis, Roche, and Nestlé also experienced slight declines, while LVMH and SAP rose by 0.38% and 1.58%, respectively"
datetime: "2025-02-04T17:26:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/227094107.md)
  - [en](https://longbridge.com/en/news/227094107.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/227094107.md)
generator: "portal-rs"
---

# European stocks "Eleven Arhats" | Astrazeneca fell about 2.2%, Sanofi, GSK, and Novo Nordisk dropped by up to 1.7%

On Tuesday (February 4th), ASML Holding's stock price in Amsterdam (ASML.NA) closed up 0.35% at €712.40. Novo Nordisk's stock price in Copenhagen (NOVOB.DC) closed down 1.18% at 7592.60 Danish Krone. In addition, AstraZeneca fell 2.18%, Sanofi dropped 1.7%, GSK declined 1.32%, and L'Oréal, Novartis, Roche, and Nestlé also fell between 0.9% and 0.23%. LVMH Group closed up 0.38%, while SAP rose 1.58%

### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [SNYNF.US](https://longbridge.com/en/quote/SNYNF.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [GSK.US](https://longbridge.com/en/quote/GSK.US.md)
- [LRLCY.US](https://longbridge.com/en/quote/LRLCY.US.md)
- [NSRGY.US](https://longbridge.com/en/quote/NSRGY.US.md)
- [NVS.US](https://longbridge.com/en/quote/NVS.US.md)
- [LVMUY.US](https://longbridge.com/en/quote/LVMUY.US.md)
- [301015.CN](https://longbridge.com/en/quote/301015.CN.md)
- [SAP.US](https://longbridge.com/en/quote/SAP.US.md)
- [NSRGF.US](https://longbridge.com/en/quote/NSRGF.US.md)
- [ASML.US](https://longbridge.com/en/quote/ASML.US.md)

## Related News & Research

- [AstraZeneca: SERENA-4 Trial Of Etcamah Palbociclib Combination Fails To Meet Primary Objective](https://longbridge.com/en/news/298875452.md)
- [AstraZeneca publishes transcript of ERS 2026 investor call and webcast](https://longbridge.com/en/news/298346504.md)
- [Health Rounds: AstraZeneca drug reduces lung disease flare-ups in late-stage trials](https://longbridge.com/en/news/298355260.md)
- [AstraZeneca COPD Drug Cuts Exacerbations as FDA Priority Review Nears](https://longbridge.com/en/news/298828016.md)
- [GSK Presents Positive Data For Jideytro In First-Line Ros1-Positive NSCLC](https://longbridge.com/en/news/298874749.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**